XML 23 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
STOCK-BASED COMPENSATION
9 Months Ended
Mar. 31, 2024
Equity [Abstract]  
STOCK-BASED COMPENSATION

 

5. STOCK-BASED COMPENSATION

 

Stock Options

 

The following table summarizes stock-based compensation expense for the three months ended March 31, 2024 and 2023. The share amounts and prices shown below reflect adjustment for a 1-for-3 reverse stock split that took effect after the close of business on November 1, 2022.

                
   Three Months
Ended March 31,
   Nine Months
Ended March 31,
 
   2024   2023   2024   2023 
Cost of Goods Sold  $34,876   $9,556   $79,377   $25,410 
Research and Development       41,140        122,198 
Selling, General and Administrative   223,338    399,918    670,014    622,182 
Stock Based Compensation Expense  $258,214   $450,014   $749,391   $769,790 

 

No compensation has been capitalized because such amounts would have been immaterial.

 

The following tables summarize stock option activity for the nine months ended March 31, 2024:

            
   Options Outstanding 
   Number of
Shares
   Weighted Average
Exercise Price
   Weighted Average
Contractual Life
 
Outstanding at June 30, 2023   1,127,140   $4.54    6.88 years 
Granted   285,257   $5.76     
Exercised   (2,000)   2.70     
Cancelled, forfeited, or expired   (4,999)   6.00      
Outstanding at March 31, 2024   1,405,398   $4.75    6.86 years 

  

The aggregate intrinsic value of the Company’s in-the-money outstanding and exercisable options as of March 31, 2024 were both $1,511,424.